logo-loader

Cello Health makes strong start to the year; in track to meet expectations

Published: 16:33 19 Jul 2018 AEST

1531983915_social-media
The company provides the full suite of marketing, communications and research services for the healthcare sector

Cello Health plc (LON:CLL) said trading in the first six months of the year had been strong, adding it expects results for the year to be in line with market forecasts.

The healthcare-focused advisory group said it saw “good growth” in revenues and earnings, while profit margins were slightly higher than the comparable period last year.

READ: Cello Health confident of "achieving a successful result in 2018" after strong start to year

The Cello Health division had a “robust” first-half, with "excellent" like-for-like gross profit growth, investors were told.

Cello Signal was described as having had a “solid” start to the year. The company said while gross profit had declined slightly year-on-year, but margins have increased, meaning operating profits will expand slightly.

The businesses acquired last year are now fully absorbed into Cello and “continue to make a good contribution”, the company said.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

10 hours, 59 minutes ago